Harnessing the evolutionary power of the immune system with the goal of curing cancer

Focusing on developing safe and effective T-cell therapies with the potential to be widely accessible to cancer patients

Two proprietary platforms:

Utilizing the natural biology of T-cells to fight cancer

Leveraging antibody discovery platform to develop highly specific antibodies

A robust pipeline that encompasses T-cell therapies targeting a variety of tumor antigens